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• A complex wound is a wound that exposes functionally 
important structures following debridement.
• NovoSorbTM Biodegradable Temporizing Matrix (BTM) is an 
entirely synthetic matrix, made from polyurethane open-cell 
foam, used in the closure of complex wounds.1
• In a complex wound, the BTM matrix is applied following 
wound debridement and before split-thickness skin grafting 
(STSG) to provide “dermal” structure in anticipation of the 
graft. 2
• Unlike other matrices, BTM does not contain biological 
materials, such a collagen. Its synthetic nature makes BTM 
more resistant to infection.1
• BTM has been used at the Lehigh Valley Health Network 
(LVHN) regional burn center in the treatment of complex 
wounds since June 2017.
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Age Range 3 months to 72 years
• Institutional Review Board (IRB) approval and informed 
consent was obtained. 
• Retrospective chart review of 33 patients identified as 
receiving application of BTM to a complex wound at the 
LVHN burn center, from June 2017 through May 2020.
• Data collected via EPIC chart review and stored in REDCap:
– Patient demographics
– Complex wound description
– BTM data
– STSG data
– Post-op visit information
• Statistical analysis completed in Excel.
To review all cases treated with NovoSorbTM BTM at the LVHN 
regional burn center regarding:
1. Complications of treatment
2. Success of wound closure
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In the past 3 years of use at the LVHN regional burn 
center, BTM has proven to be a successful bridge to STSG, in 
complex wounds, with a primary STSG success rate of 97% 
and a low infection rate, with all infections treated locally. The 
post-hospital discharge outcomes are generally good due to the 
complexity of these wounds and the worse outcomes, such as 
amputation, that would have preceded without the use of this 
dermal matrix. Finally, BTM proved useful in both pediatric and 
adult patients, as well as in use on a variety of different 
locations throughout the body. 
Complications of Treatment
Reapplication of BTM
(for extra dermal support): 3 (8%)
Infection of BTM: 6 (15%)
Success of Wound Closure*
Primary graft success: 35 (97%)






Post Hospital Discharge Outcomes
Decreased range of motion 
or gait abnormalities: 12 out of 24
Contracture: 12 out of 28(10%-80% contracture)














Wound debridement BTM application STSG
Complex Wounds
Locations: Head, neck, trunk, upper 
arm, lower arm, hand, thigh, lower leg, 
and/or foot
Causes: Burn, infection, trauma, or 
amputation
Demographics
Reason for BTM Application to Complex Wound
Table 1. Complications relating to the 
BTM treatment in the complex wound. 
Table 2. Success of wound closure relating 
to STSG.
Table 3. Complex 
wound outcomes 
evaluated from follow 
up office visits 13 
days to 2.75 years 
post hospital 
discharge following 
STSG. Not all follow 
up information was 





Figure 1. Reason for BTM application to 
complex wound before STSG. The other 
















* One patient passed away in the hospital due 
to sepsis and never received STSG.
Figure 2. Photos documenting the healing process of a complex upper arm 
wound. (1) Initial debridement of wound via fasciotomy. (2) Wound post VAC 
and prior to BTM application. (3) BTM application to the complex wound. (4) 
Wound with integrated BTM prior to STSG. (5) Thin STSG applied to wound 
bed. (3) Healed complex wound 18 months post STSG.
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